Therefore, GARP might be an early prognostic biomarker because it is specifically expressed on the surface of tumor-infiltrating Tregs, and lung cancer patients with early stage had more GARP+ Tregs than advanced cancer patients. Here, LRRC32 is linked to lung carcinoma.